Skip to main content
logo
Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
34.19
-0.41 (-1.18%)
At close: Aug 28, 2026, 4:00 PM EDT
33.91
-0.28 (-0.82%)
After-hours: Aug 28, 2026, 7:58 PM EDT

Vera Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-401.9-299.62-152.15-95.99-89.06-32.61
Depreciation & Amortization
0.540.470.110.02-0.850.18
Loss (Gain) From Sale of Assets
------2.69
Asset Writedown & Restructuring Costs
------1
Loss (Gain) From Sale of Investments
-4.5-6.98-8.97-4.430.810.89
Stock-Based Compensation
49.7837.9320.811.498.893.01
Other Operating Activities
18.554.112.872.555.865
Change in Accounts Payable
1.1213.91-3.45-0.8710.610.48
Change in Other Net Operating Assets
-2.249.086.11-4.95-3.863.04
Operating Cash Flow
-338.65-241.1-134.68-92.18-67.6-23.71
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.26-0.63-0.97-0.06-0.06-
Sale of Property, Plant & Equipment
-----0.8
Sale (Purchase) of Intangibles
-0.26-----5
Investment in Securities
60.99195.72-424.06-39.37-70.49-
Other Investing Activities
-15-0.8----
Investing Cash Flow
45.47194.29-425.03-39.43-70.55-4.2

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-23.34-24.7419.824.92
Total Debt Issued
-23.34-24.7419.824.92
Net Debt Issued (Repaid)
-23.34-24.7419.824.92
Issuance of Common Stock
310.84306.98645.91116.0688.2151.73
Repurchase of Common Stock
---0.01---
Other Financing Activities
-17.91-21.42-39.23-7.26-6.1-2.77
Financing Cash Flow
292.94308.9606.67133.54101.9353.88

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.25262.0846.971.93-36.2225.97

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-338.91-241.73-135.65-92.24-67.66-23.71
Free Cash Flow Growth
------
Free Cash Flow Per Share
-4.97-3.76-2.45-2.16-2.55-1.76
Levered Free Cash Flow
-212.95-139.02-84.35-58.02-42.37-20.38
Unlevered Free Cash Flow
-208.24-134.32-79.58-55.66-41.75-20.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
6.766.726.653.350.90.02
Change in Working Capital
-1.1222.992.66-5.826.753.51
SEC Filings: 10-K · 10-Q